Scholars Central

Editor

Mark Hylton Sutherland

Molecular Pharmacology, University of Bradford, UK, Institute of Cancer Therapeutics

About

As published by the journal they serve.

Dr Mark Sutherland is a Senior Experimental Officer at the Institute of Cancer Therapeutics, University of Bradford. After completing his MSc in Molecular Biology at the University of Stellenbosch, South Africa he worked for a few years as a school teacher and University Lecturer. He was offered a PhD at the Charite – Campus Benjamin Franklin, Berlin, Germany where he received his degree. He then worked for a number of years as a PDRA in Berlin in the field of immunotoxins. In 2005 he moved to the University of Bradford. In his current role he carries out research for a number a projects within the Institute, teach laboratory skills to MSc and PhD students, and lectures undergraduate and MSc students. His current research is in the field of integrins as a target for new anti-cancer drugs in prostate cancer and melanoma, as well as the role of sialyltransferases in neuroblastoma.

Research interests

  • Immunotoxins Dual/multi-integrin antagonism in prostate cancer and melanoma Polysialyltransferase (the tumour cell glycocalyx as a therapeutic target) in neuroblastoma

Journals they serve

The seats these journals name them in.

Articles we hold

Articles in the journals they serve whose byline carries this name.

No article in our collection carries this name on its byline. Not every article names its authors in a way that can be matched, so this is not a list of everything they have written.

This page holds what the journals publish about this profile: no contact details, and nothing gathered from anywhere else. Ask us to correct or remove this profile.

For authors and organisers

Publish, present and keep up with your field

Find the right journal for your paper and submit your manuscript.

Photo: Pexels